BFSG LLC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.57M | Sell |
22,116
-248
| -1% | -$53.4K | 0.49% | 60 |
|
|
2026
Q1 | $4.86M | Sell |
22,364
-245
| -1% | -$54.3K | 0.46% | 69 |
|
|
2025
Q4 | $5.17M | Sell |
22,609
-332
| -1% | -$75.6K | 0.5% | 62 |
|
|
2025
Q3 | $5.31M | Sell |
22,941
-86
| -0.4% | -$17.5K | 0.51% | 60 |
|
|
2025
Q2 | $4.27M | Buy |
23,027
+375
| +2% | +$69.7K | 0.48% | 69 |
|
|
2025
Q1 | $4.75M | Sell |
22,652
-1,414
| -6% | -$275K | 0.58% | 59 |
|
|
2024
Q4 | $4.28M | Buy |
24,066
+19
| +0.1% | +$3.49K | 0.5% | 69 |
|
|
2024
Q3 | $4.75M | Sell |
24,047
-1,451
| -6% | -$271K | 0.55% | 58 |
|
|
2024
Q2 | $4.37M | Sell |
25,498
-393
| -2% | -$65.1K | 0.55% | 59 |
|
|
2024
Q1 | $4.71M | Sell |
25,891
-27
| -0.1% | -$4.65K | 0.62% | 49 |
|
|
2023
Q4 | $4.02M | Sell |
25,918
-240
| -0.9% | -$35K | 0.58% | 60 |
|
|
2023
Q3 | $3.9M | Buy |
26,158
+993
| +4% | +$146K | 0.63% | 58 |
|
|
2023
Q2 | $3.39M | Buy |
25,165
+345
| +1% | +$50.6K | 0.58% | 64 |
|
|
2023
Q1 | $3.96M | Buy |
24,820
+34
| +0.1% | +$5.2K | 0.73% | 49 |
|
|
2022
Q4 | $4.01M | Buy |
24,786
+170
| +0.7% | +$26.1K | 0.8% | 41 |
|
|
2022
Q3 | $3.3M | Buy |
24,616
+260
| +1% | +$37.3K | 0.7% | 55 |
|
|
2022
Q2 | $3.73M | Buy |
24,356
+72
| +0.3% | +$11K | 0.67% | 59 |
|
|
2022
Q1 | $3.94M | Sell |
24,284
-742
| -3% | -$108K | 0.62% | 55 |
|
|
2021
Q4 | $3.39M | Sell |
25,026
-303
| -1% | -$35.8K | 0.47% | 70 |
|
|
2021
Q3 | $2.73M | Buy |
25,329
+499
| +2% | +$57K | 0.42% | 74 |
|
|
2021
Q2 | $2.8M | Sell |
24,830
-276
| -1% | -$31.1K | 0.5% | 71 |
|
|
2021
Q1 | $2.72M | Sell |
25,106
-1,010
| -4% | -$108K | 0.44% | 73 |
|
|
2020
Q4 | $2.8M | Buy |
26,116
+250
| +1% | +$24K | 0.46% | 68 |
|
|
2020
Q3 | $2.27M | Buy |
25,866
+322
| +1% | +$30.3K | 0.42% | 74 |
|
|
2020
Q2 | $2.51M | Buy |
25,544
+340
| +1% | +$29.9K | 0.54% | 62 |
|
|
2020
Q1 | $1.92M | Buy |
25,204
+14
| +0.1% | +$1.19K | 0.49% | 68 |
|
|
2019
Q4 | $2.23M | Buy |
25,190
+76
| +0.3% | +$6.31K | 0.42% | 78 |
|
|
2019
Q3 | $1.9M | Sell |
25,114
-209
| -0.8% | -$14.3K | 0.42% | 72 |
|
|
2019
Q2 | $1.84M | Sell |
25,323
-189
| -0.7% | -$14.9K | 0.72% | 44 |
|
|
2019
Q1 | $2.06M | Sell |
25,512
-1,270
| -5% | -$104K | 0.77% | 44 |
|
|
2018
Q4 | $2.47M | Sell |
26,782
-850
| -3% | -$74.7K | 1.12% | 29 |
|
|
2018
Q3 | $2.61M | Sell |
27,632
-492
| -2% | -$46.7K | 1.1% | 33 |
|
|
2018
Q2 | $2.61M | Buy |
28,124
+59
| +0.2% | +$5.76K | 1.15% | 25 |
|
|
2018
Q1 | $2.66M | Sell |
28,065
-666
| -2% | -$73.2K | 1.18% | 24 |
|
|
2017
Q4 | $2.78M | Sell |
28,731
-1,594
| -5% | -$150K | 1.17% | 26 |
|
|
2017
Q3 | $2.69M | Sell |
30,325
-539
| -2% | -$41K | 1.22% | 26 |
|
|
2017
Q2 | $2.24M | Sell |
30,864
-1,536
| -5% | -$103K | 1.1% | 31 |
|
|
2017
Q1 | $2.11M | Buy |
+32,400
| New | +$2.04M | 1.06% | 35 |
|
Other funds holding ABBV
BFSG LLC's ABBV Position: Q2 2026 in Review
BFSG LLC reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $53.4K and leaving 22,116 shares worth $5.57M. The position accounts for 0.49% of the portfolio, ranked #60.
BFSG LLC first reported a position in ABBV in Q1 2017 and has held it in 38 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- BFSG LLC held 22,116 shares of AbbVie worth $5.57M as of Q2 2026.
- BFSG LLC sold 248 AbbVie shares in Q2 2026, an estimated $53.4K.
- AbbVie made up 0.49% of BFSG LLC's portfolio in Q2 2026, its #60 holding.
- BFSG LLC first reported a position in AbbVie in Q1 2017 and has held it in 38 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.